Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | BIIB | TMO |
|---|
| Close | 216.01 | 648.43 |
| Market Cap | $31.9B | $240B |
| 1M | +3.28% | +10.75% |
| P/E (TTM) | 38.2 | 34.4 |
| Forward P/E | 14.0 | 21.8 |
| P/E 5-Yr Percentile | 100 | 65 |
| P/S | 3.2 | 5.2 |
| P/B | 1.7 | 4.6 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $2.5B | $12.0B |
| Revenue YoY | +1.9% | +10.5% |
| Gross Margin | 73.3% | — |
| Latest Quarter EPS | 2.15 | 4.68 |
| Avg Post-Earnings Move | ±1.6% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 2.36% |
| 90-Day Net Insider Buying | −$0.24M | −$38.9M |
BIIB · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
